
    
      10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the
      other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective
      is to evaluate and compare the dose received by the prostate using two repositioning
      techniques.
    
  